Skip to main content
. 2016 Nov 20;2016:3094783. doi: 10.1155/2016/3094783

Table 2.

Average (mean ± SD) full blood count and platelets during treatment of the rats with NVP, INH, and PAR over the study period.

Group RCC (×1012/l) Hb (g/dl) Hct (l/l) MCV (fl) MCH (pg) MCHC (g/dl) Plt (×109/l) WCC (×109/l) Neu (×109/l) Ly (×109/l) Mo (×109/l) Eos (×109/l) Bas (×109/l)
Untreated
0 days 6.28 ± 0.2 12.9 ± 0.3 0.398 ± 0.01 63.5 ± 2.5 20.5 ± 0.4 32.3 ± 0.8 860 ± 221.1 6.95 ± 2.7 0.77 ± 0.2 4.67 ± 1.8 0.19 ± 0.1 0.02 ± 0.0 0.01 ± 0.0
S
2 days 6.67 ± 0.2 13.7 ± 0.1 0.422 ± 0.01 63.3 ± 2.3 20.6 ± 0.6 32.4 ± 0.6 849 ± 81.6 6.50 ± 0.9 0.60 ± 0.2 5.18 ± 0.7 0.21 ± 0.0 0.50 ± 0.2 0.01 ± 0.0
7 days 7.53 ± 0.9 15.3 ± 1.7 0.451 ± 0.04 60.1 ± 2.5 20.3 ± 0.2 33.9 ± 1.2 1033 ± 79.8 5.44 ± 2.4 1.03 ± 0.8 4.07 ± 2.0 0.30 ± 0.3 0.04 ± 0.0 0.01 ± 0.0
14 days 6.77 ± 0.6 13.9 ± 1.1 0.417 ± 0.03 61.8 ± 2.8 20.5 ± 0.6 33.2 ± 0.6 721 ± 196.4 5.22 ± 1.2 0.63 ± 0.5 4.21 ± 0.7 0.18 ± 0.1 0.18 ± 0.1 0.05 ± 0.0
28 days 7.07 ± 0.7 13.9 ± 1.3 0.390 ± 0.04 55.1 ± 1.0 19.7 ± 0.1 35.8 ± 0.6 961 ± 172.5 7.38 ± 1.0 0.91 ± 0.2 6.15 ± 0.8 0.24 ± 0.1 0.07 ± 0.0 0.01 ± 0.0
42 days 6.93 ± 0.8 13.4 ± 1.8 0.374 ± 0.05 53.9 ± 1.0 19.3 ± 0.4 35.8 ± 0.2 839 ± 166.0 3.93 ± 0.3 0.54 ± 0.1 3.23 ± 0.3 0.11 ± 0.0 0.04 ± 0.0 0.01 ± 0.0
NVP
2 days 6.51 ± 0.2 13.6 ± 0.4 0.408 ± 0.01 62.7 ± 0.8 20.9 ± 0.1 33.2 ± 0.3 854 ± 209.3 3.48 ± 0.8 1.02 ± 0.1 1.88 ± 0.3 0.10 ± 0.0 0.48 ± 0.4 0.00 ± 0.0
7 days 7.14 ± 0.3 14.2 ± 0.5 0.424 ± 0.02 59.5 ± 1.8 19.9 ± 0.6 33.5 ± 0.5 779 ± 141.3 5.54 ± 1.3 0.76 ± 0.3 3.81 ± 0.9 0.49 ± 0.2 0.48 ± 0.2 0.03 ± 0.0
14 days 6.97 ± 0.3 13.9 ± 0.4 0.415 ± 0.01 59.5 ± 2.2 19.9 ± 0.6 33.5 ± 0.3 1013 ± 73.0 4.86 ± 0.7 1.08 ± 0.2 3.38 ± 0.4 0.37 ± 0.1 0.02 ± 0.0 0.01 ± 0.0
28 days 7.36 ± 0.6 14.2 ± 1.1 0.404 ± 0.03 55.0 ± 0.7 19.3 ± 0.3 35.0 ± 0.6 876 ± 17.2 6.07 ± 0.6 1.09 ± 0.2 4.62 ± 0.7 0.28 ± 0.2 0.08 ± 0.1 0.01 ± 0.0
42 days 7.73 ± 0.3 14.5 ± 0.3 0.405 ± 0.00 52.5 ± 2.3 18.8 ± 0.5 35.8 ± 0.8 1052 ± 115.6 5.42 ± 0.1 1.52 ± 0.6 3.52 ± 0.6 0.33 ± 0.0 0.04 ± 0.0 0.01 ± 0.0
INH
2 days 6.57 ± 0.3 13.4 ± 0.4 0.416 ± 0.01 63.4 ± 2.0 20.5 ± 0.3 32.3 ± 0.7 880 ± 54.5 5.86 ± 1.1 0.59 ± 0.0 5.02 ± 1.1 0.21 ± 0.1 0.03 ± 0.0 0.01 ± 0.0
7 days 6.05 ± 0.6 12.7 ± 1.1 0.381 ± 0.04 63.0 ± 0.6 21.0 ± 0.2 33.3 ± 0.2 478 ± 19.1 5.98 ± 0.8 0.56 ± 0.1 5.10 ± 0.8 0.19 ± 0.1 0.04 ± 0.0 0.02 ± 0.0
14 days 6.65 ± 0.6 9.8 ± 5.4 0.394 ± 0.04 59.2 ± 2.7 19.8 ± 0.6 33.4 ± 0.7 494 ± 50.2 5.78 ± 1.1 0.61 ± 0.1 4.91 ± 0.9 0.23 ± 0.1 0.03 ± 0.0 0.00 ± 0.0
28 days 7.27 ± 0.4 14.3 ± 0.8 0.406 ± 0.02 55.9 ± 0.6 19.7 ± 0.1 35.3 ± 0.4 845 ± 116.0 5.44 ± 0.4 0.66 ± 0.1 4.56 ± 0.4 0.17 ± 0.1 0.04 ± 0.0 0.01 ± 0.0
42 days 7.25 ± 0.7 13.9 ± 1.2 0.390 ± 0.04 53.8 ± 1.9 19.2 ± 0.4 35.6 ± 0.8 785 ± 152.7 5.11 ± 0.9 0.84 ± 0.1 4.05 ± 0.6 0.22 ± 0.0 0.07 ± 0.0 0.01 ± 0.0
PAR
2 days 6.77 ± 0.0 14.8 ± 0.0 0.461 ± 0.00 68.1 ± 0.0 21.9 ± 0.0 32.1 ± 0.0 419 ± 0.0 7.54 ± 0.0 0.75 ± 0.0 5.96 ± 0.0 0.37 ± 0.0 0.46 ± 0.0 0.01 ± 0.0
7 days 6.75 ± 0.2 13.9 ± 0.1 0.426 ± 0.00 63.2 ± 2.4 20.7 ± 0.8 32.7 ± 0.1 807 ± 22.8 7.32 ± 0.8 0.80 ± 0.2 6.22 ± 0.8 0.23 ± 0.0 0.07 ± 0.0 0.01 ± 0.0
14 days 6.66 ± 0.2 13.8 ± 0.3 0.411 ± 0.01 61.7 ± 0.5 20.7 ± 0.1 33.6 ± 0.4 834 ± 43.0 4.19 ± 0.4 0.55 ± 0.0 3.42 ± 0.6 0.09 ± 0.1 0.13 ± 0.2 0.00 ± 0.0
28 days 7.10 ± 0.2 14.1 ± 0.2 0.397 ± 0.00 56.0 ± 2.2 19.8 ± 0.8 35.4 ± 0.4 880 ± 87.0 5.32 ± 1.2 0.88 ± 0.1 4.19 ± 1.1 0.21 ± 0.1 0.04 ± 0.0 0.01 ± 0.0
42 days 7.33 ± 0.3 14.5 ± 0.3 0.401 ± 0.01 54.8 ± 1.8 19.8 ± 0.5 36.2 ± 0.3 961 ± 85.8 4.91 ± 0.3 0.80 ± 0.2 3.86 ± 0.4 0.20 ± 0.0 0.05 ± 0.0 0.01 ± 0.0

RCC: red cell count; Hb: haemoglobin; Hct: haematocrit; MCV: mean corpuscular volume; MCH: mean corpuscular haemoglobin; MCHC: mean corpuscular haemoglobin concentration; Plt: platelets; WCC: white cell count; Neu: neutrophils; Ly: lymphocytes; Mo: monocytes; Eos: eosinophils; Bas: basophils, S: saline; INH: isoniazid; NVP: nevirapine; PAR: paracetamol; p ≤ 0.05.